SARS-CoV-2 beta variant elicits variant specific and cross-reactive antibodies

One recent study assessed the serum of Beta variant infected patients to determine whether major non-VOC antibodies could neutralize this virus.

Related Keywords

Juan Gaertner Shutterstock , ,Juan Gaertner ,Antibodies ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Ce2 ,Ngiotensin ,Ngiotensin Converting Enzyme 2 ,Ntibody ,Fell ,Coronavirus ,Nzyme ,Frequency ,Gene ,Genes ,Germline ,Immunity ,Utation ,Pandemic ,Protein ,Eceptor ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Vaccine ,Virus ,